Literature DB >> 26862222

What's in a name? The clinical features of facioscapulohumeral muscular dystrophy.

Karlien Mul1, Saskia Lassche1, Nicol C Voermans1, George W Padberg1, Corinne Gc Horlings1, Baziel Gm van Engelen1.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is an inherited and progressive muscle disorder. Although its name suggests otherwise, it comprises weakness of the facial, shoulder and upper arm muscles, and also of the trunk and leg muscles. Its severity and disease course vary greatly and mild or early FSHD can be difficult to recognise. Knowledge of its subtle signs and symptoms can lead directly to the correct diagnosis without diagnostic delay and without needing multiple diagnostic procedures. We give an overview of the signs and symptoms of FSHD in severe as well as in mild cases, to facilitate correct and instant recognition of this relatively common muscle disorder. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  diagnosis; facioscapulohumeral muscular dystrophy; signs and symptoms

Mesh:

Year:  2016        PMID: 26862222     DOI: 10.1136/practneurol-2015-001353

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  29 in total

Review 1.  Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era.

Authors:  Stefania Zampatti; Luca Colantoni; Claudia Strafella; Rosaria Maria Galota; Valerio Caputo; Giulia Campoli; Giulia Pagliaroli; Stefania Carboni; Julia Mela; Cristina Peconi; Stefano Gambardella; Raffaella Cascella; Emiliano Giardina
Journal:  Neurogenetics       Date:  2019-03-25       Impact factor: 2.660

2.  Adding quantitative muscle MRI to the FSHD clinical trial toolbox.

Authors:  Karlien Mul; Sanne C C Vincenten; Nicol C Voermans; Richard J L F Lemmers; Patrick J van der Vliet; Silvère M van der Maarel; George W Padberg; Corinne G C Horlings; Baziel G M van Engelen
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

3.  SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain.

Authors:  Richard J L F Lemmers; Nienke van der Stoep; Patrick J van der Vliet; Steven A Moore; David San Leon Granado; Katherine Johnson; Ana Topf; Volker Straub; Teresinha Evangelista; Tahseen Mozaffar; Virginia Kimonis; Natalie D Shaw; Rita Selvatici; Alessandra Ferlini; Nicol Voermans; Baziel van Engelen; Sabrina Sacconi; Rabi Tawil; Meindert Lamers; Silvère M van der Maarel
Journal:  J Med Genet       Date:  2019-06-26       Impact factor: 6.318

4.  Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.

Authors:  Karlien Mul; Chad Heatwole; Katy Eichinger; Nuran Dilek; William B Martens; Baziel G M Van Engelen; Rabi Tawil; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2018-04-17       Impact factor: 3.217

Review 5.  Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophy.

Authors:  Bo Bao; Rika Maruyama; Toshifumi Yokota
Journal:  Intractable Rare Dis Res       Date:  2016-08

6.  A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1.

Authors:  Mariëlle Wohlgemuth; Richard J Lemmers; Marianne Jonker; Elly van der Kooi; Corinne G Horlings; Baziel G van Engelen; Silvere M van der Maarel; George W Padberg; Nicol C Voermans
Journal:  Neurology       Date:  2018-07-11       Impact factor: 9.910

7.  Chromosome 10q-linked FSHD identifies DUX4 as principal disease gene.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Ana Blatnik; Judit Balog; Janez Zidar; Don Henderson; Rianne Goselink; Stephen J Tapscott; Nicol C Voermans; Rabi Tawil; George W A M Padberg; Baziel Gm van Engelen; Silvère M van der Maarel
Journal:  J Med Genet       Date:  2021-01-12       Impact factor: 6.318

8.  Increased resistance towards fatigability in patients with facioscapulohumeral muscular dystrophy.

Authors:  Matteo Beretta-Piccoli; Luca Calanni; Massimo Negro; Giulia Ricci; Cinzia Bettio; Marco Barbero; Angela Berardinelli; Gabriele Siciliano; Rossella Tupler; Emiliano Soldini; Corrado Cescon; Giuseppe D'Antona
Journal:  Eur J Appl Physiol       Date:  2021-03-01       Impact factor: 3.078

9.  Effects of weakness of orofacial muscles on swallowing and communication in FSHD.

Authors:  Karlien Mul; Kiera N Berggren; Mattie Y Sills; Ayla McCalley; Baziel G M van Engelen; Nicholas E Johnson; Jeffrey M Statland
Journal:  Neurology       Date:  2019-01-25       Impact factor: 9.910

10.  Preserved single muscle fiber specific force in facioscapulohumeral muscular dystrophy.

Authors:  Saskia Lassche; Nicol C Voermans; Robbert van der Pijl; Marloes van den Berg; Arend Heerschap; Hieronymus van Hees; Benno Kusters; Silvère M van der Maarel; Coen A C Ottenheijm; Baziel G M van Engelen
Journal:  Neurology       Date:  2020-01-21       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.